Skip to main content

Table 2 Univariate- and multivariate Cox proportional hazard regression models of analyzed factors and clinical co-factors. Significant P-values are written in italics

From: TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Survival outcome

Univariate survival analysis

Multivariate survival analysis

Factor

Cox proportional hazard model

Cox proportional hazard model

Co-factors

P-value (Hazard ratio, [95 % confidence intervals])

P-value (Hazard ratio, [95 % confidence intervals])

Progression free survival

  

Hot Spot/Direct DNA Contact MUT-TP53

0.0046 (1.97, [1.14-3.01])

0.0083 (1.95, [1.19–3.21])

 Age

 

0.94 (1.0, [0.96–1.05])

 Sex

  

  Female

 

1.00 (1.00, [1.00–1.00])

  Male

 

0.18 (0.63, [0.32–1.25])

 IPI

  

  Low

 

1.00 (1.00, [1.00–1.00])

  High

 

0.36 (1.45, [0.65–3.24])

Overall survival

  

Hot Spot/Direct DNA Contact MUT-TP53

0.028 (1.67, [1.06–2.67])

0.012 (1.86, [1.14–3.01])

 Age

 

0.20 (1.03, [0.98–1.08])

 Sex

  

  Female

 

1.00 (1.00, [1.00–1.00])

  Male

 

0.35 (0.71, [0.34–1.46])

 IPI

  

  Low

 

1.00 (1.00, [1.00–1.00])

  High

 

0.42 (1.44, [0.59–3.48])

Progression free survival

  

Double Hit, MUT-TP53 and MIR34A-meth

0.010 (2.96, [1.29–6.76])

0.066 (2.30, [0.95–5.57])

 Age

 

0.73 (0.99, [0.95–1.04])

 Sex

  

  Female

 

1.00 (1.00, [1.00–1.00])

  Male

 

0.07 (0.50, [0.24–1.06])

 IPI

  

  Low

 

1.00 (1.00, [1.00–1.00])

  High

 

0.26 (1.69, [0.68–4.19])